ArticleJournal of cellular and molecular medicine2026
Rapamycin Partially Reverts Cavernoma Endothelial Cell Phenotype and, When Combined With Lapatinib, Ameliorates Chronic Lesions.
Mar García-Colomer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.